Dr. Francesca Re

Dr. Francesca Re |Clyto Access

University of Milano-Bicocca, Italy

Editorial Board Member

Expertise: Neuroscience, Nanotechnology, Nanomedicine, Nanoparticles for therapy and diagnosis of Alzheimer's disease, Nanoparticle for gene therapy of melanoma and rheumatoid arthritis

Bio:
Dr  Re Francesca completed Master of Science degree in Medical Biotechnology on 15/07/2005 at University of Milano-Bicocca. PhD in Neuroscience (04/12/2008) at University of Milano-Bicocca. At Department of Experimental Medicine, University of Milano-Bicocca she performed her research activities on preparation and characterization of nanoparticles for Alzheimer’s disease therapy as  project collaborator (from 12/2008 to 01/2009); she has won of research grant (from 02/2009 to 12/2009) and she was  researcher at fixed time (from December 2009 to December 2012). She has conducted research abroad at Department of Biological Sciences, University of Warwick, Coventry CV4 7AL (UK) and at Neurogenetics laboratory, Academic Medical Center (AMC), University of Amsterdam, Amsterdam (NL). She is professor of Pathophysiology at  Faculty of Biotechnology and Biosciences, degree in Biotechnology at the University of Milan-Bicocca, Professor of Nanomedicine to the Master of Science degree in Medical Biotechnology at University of Milan-Bicocca, professor of structure, function and metabolism of biological molecules to the Degree Course in Medicine and Surgery at University of Milan-Bicocca; contributor to tutoring-integrative educational, preparatory and recovery (School of Biochemistry) at Faculty of Medicine, Master of Science in Medicine at University of Milan-Bicocca. She holds of an international patent No. MI2008A001052 of 06.10.2008 entitled "Liposomes able to efficiently bind the peptide beta-amyloid" and of a U.S. patent No. 13/536, 851 of 28.06.2012 entitled "Liposomes active in vivo on neurodegenerative diseases (Alzheimer's disease in particular)." She has participated in more than 20 international conferences and more than half as invited speaker. She is reviewer of several papers on international journals. She is coordinator of a project entitled “Evaluation of the toxicity of nanoparticles designed for the therapy and diagnosis of neurodegenerative diseases” funded by Fondazione Banca del Monte di Lombardia (€ 20.000). She is in the Editorial Board of Nanobiomedicine Journal. She has won the competition“63rd Lindau Nobel Laureate Meeting in Chemistry” (2013).

Related Journals & Conferences :

International Journal of Nanotechnology and Nanomedicine Research